Posted on 11/9/20
Krystal Biotech Reports Third Quarter 2020 Financial Results
PITTSBURGH--(BUSINESS WIRE)--Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprietary, engineered herpes simplex virus type 1 vector (HSV-1) platform, today reported . . .
Posted on 11/9/20
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
WEST CHESTER, Penn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today . . .
Posted on 11/9/20
Homology Medicines Announces $60 Million Equity Investment from Pfizer
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed . . .
Posted on 11/9/20
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results . . .
Posted on 11/9/20
Genesis Healthcare Reports Third Quarter 2020 Results
KENNETT SQUARE, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating . . .
Posted on 11/9/20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
DEVON, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/9/20
3 Red Flags for Inovio Pharmaceuticals' Future
In the early days of the coronavirus pandemic, Inovio Pharmaceuticals (NASDAQ:INO) was an exciting frontrunner in the vaccine race. The company garnered attention after it claimed . . .
Posted on 11/6/20
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
JERSEY CITY, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to potentially overcome and prevent difficult-to-treat and . . .
Posted on 11/6/20
Genesis Healthcare to Release Third Quarter 2020 Results and Provide COVID-19 Update
KENNETT SQUARE, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN), one of the nation’s largest providers of post-acute care, today announced that it expects . . .
Posted on 11/6/20
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness . . .
Posted on 11/6/20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
BEDMINSTER, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to . . .
Posted on 11/6/20
Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
One of America's largest pharmaceutical companies is about to get a little bigger. On Thursday, Merck (NYSE:MRK) agreed to acquire a privately held biotech start-up called . . .
Posted on 11/6/20
Caladrius Biosciences Provides Corporate Update
BASKING RIDGE, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 11/6/20
CorMedix Provides Business Update
BERKELEY HEIGHTS, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 11/6/20
Celldex Provides Corporate Update
HAMPTON, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2020. . . .
Posted on 11/5/20
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended . . .
Posted on 11/5/20
AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent to $49.2 . . .
Posted on 11/5/20
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
WARREN, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, . . .
Posted on 11/5/20
Outlook Therapeutics Secures $10 Million
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg
Posted on 11/5/20
VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
BRIDGEWATER, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/5/20
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
EWING, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS), a pharmaceutical technology company, today reported financial and operating results for the third . . .
Posted on 11/5/20
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
CRANBURY, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for . . .
Posted on 11/4/20
AdaptHealth Announces Third Quarter 2020 Financial Results
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .
Posted on 11/4/20
Aclaris Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
WAYNE, Pa., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, . . .
Philadelphia
